Pharmaceutical Company in India

Overview

India’s pharmaceutical market is expanding rapidly, driven by demographic shifts, rising burden of chronic diseases, and increasing demand for accessible, high-quality healthcare. However, persistent gaps in early diagnosis, continuity of care, and affordability continue to challenge the healthcare ecosystem. These dynamics underscore the need for timely, scalable, and patient-centric solutions.

This evolving landscape is driving a shift toward a more integrated care approach and innovation tailored to India’s diverse healthcare needs. Our India Region Formulations (IRF) business is at the forefront of this transformation, consistently outperforming the market through data-driven solutions, strong execution, and strategic partnerships.

Our leadership is anchored in deep expertise and strong market presence across our key therapy areas, enabling us to deliver cutting-edge patient outcomes while sustaining competitive advantage in the Indian pharma market.

India at a Glance

8th largest company in the Indian Pharmaceutical Market (IPM)

5 Lupin brands ranked in top 300 IPM brands

#1 in Anti-TB, #2 in Respiratory, #3 in both Anti-Diabetes and Cardiology segments

5 flagship brands - Gluconorm-G, Budamate, Huminsulin, Ivabrad, and Rablet ranked in the top 300 IPM

19 brands featured in top 500 IPM

Supported by 350,000+ HCPs across India

What We Do

Our IRF business delivers a differentiated and market-leading portfolio across our top five therapies, Cardiology, Anti-Diabetes, Respiratory, Gastroenterology, and Anti-Infectives. We build depth, scale, and sustain relevance across these high-impact therapies to drive consistent performance and patient reach.

As a deeply rooted India business, we are committed to making a meaningful impact across communities by expanding access to affordable, high-quality, trusted treatments that alleviate disease burden and improve quality of life.

Our focus goes beyond medicine, as we strive to bring care closer to patients through innovation, awareness, and inclusive healthcare solutions. Our digital initiatives like Anya, our AI-powered multilingual health chatbot, reflect this commitment by offering reliable health guidance and empowering individuals to make informed decisions about their well-being.

Together, we continue to advance a future where compassionate care and accessible innovation reach every corner of India.

Patient Support Programs

At Lupin, our mission is rooted in a deeper purpose, to catalyze treatments that transform hope into healing. Guided by this belief, we continue to innovate beyond medicine, creating meaningful initiatives that place patients at the heart of everything we do.

Our patient support programs are designed to make a real difference, offering care that impacts lives with empathy and understanding. Through our flagship initiatives like HuMrahi and JAI, we stand alongside patients and caregivers, helping them navigate challenges with confidence, continuity, and compassion.

Alongside these, several other programs quietly work every day to ensure no patient feels alone. Together, these efforts reflect our commitment not just to treating illness but to nurturing well-being, because at Lupin, every step of support is a step toward healing.

View our Patient Support Programs

Therapies

Our India business focuses on key therapy areas, aiming to deliver affordable care with quality and trusted outcomes for people.

CardiologyAnti-DiabetesRespiratoryGastroenterologyAnti-Infectives

Patient Support Programs

Lupin is committed to extending care beyond prescriptions through patient-centric programs that empower individuals and improve health outcomes. From setting up 10,000+ health camps to battle diabetes and cardiac conditions to India's 1st digital asthma educator platform, our deep patient engagement and purpose-driven innovation are bringing us one step closer to a healthier world.

Explore our programs

Way Forward

As India’s healthcare landscape continues to evolve, our focus remains firmly on building a future that is equitable, innovative, and patient-centric. We aim to deepen our presence across therapies while accelerating investments in digital health, data-driven insights, and differentiated access models that bridge gaps in early diagnosis, treatment, and rehabilitative care.

Looking ahead, our journey at Lupin is guided by our purpose, to catalyze treatments that transform hope into healing through inclusive, responsive, and impactful strategies.

Together, we will continue to enable better health outcomes, empower patients, and shape a healthier, more resilient India.